| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |